Comparison of Efficacy of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A Narrative Review. IJPHRD. 2020;11(7):1344-1350. doi:10.37506/ijphrd.v11i7.10282